84 related articles for article (PubMed ID: 29553086)
1. Comment on "Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report".
Nomoto H; Miyoshi H; Sekizaki T; Atsumi T
Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):165-166. PubMed ID: 29553086
[No Abstract] [Full Text] [Related]
2. Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report.
Komatsu H; Izumi N; Tsukioka T; Toda M; Hara K; Miyamoto H; Nishiyama N
Ann Thorac Cardiovasc Surg; 2018 Jun; 24(3):151-153. PubMed ID: 29249770
[TBL] [Abstract][Full Text] [Related]
3. [The prescription of serum tumor markers in a general hospital].
Watine J; Charet JC; Augé MC
Presse Med; 1998 May; 27(18):862, 864. PubMed ID: 9767874
[No Abstract] [Full Text] [Related]
4. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
Lee YC; Yang PC; Kuo SH; Luh KT
J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
[TBL] [Abstract][Full Text] [Related]
5. [Determination of carcinoembryonic antigen in lung cancer using an immunoenzyme assay].
Ial'chenko NA; Lagutin VD; Levik NN; Nekhaev OK
Lab Delo; 1991; (6):36-8. PubMed ID: 1717751
[TBL] [Abstract][Full Text] [Related]
6. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer.
Dong Y; Zheng X; Yang Z; Sun M; Zhang G; An X; Pan L; Zhang S
J Cancer Res Ther; 2016 Oct; 12(Supplement):34-36. PubMed ID: 27721249
[TBL] [Abstract][Full Text] [Related]
7. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
Buccheri G; Ferrigno D
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
[TBL] [Abstract][Full Text] [Related]
8. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
9. Annual periodic increases in serum carcinoembryonic antigen concurrent with ground-glass opacity in the lung: report of a case.
Sakuma T; Iwata Y; Ueda Y; Gu X; Sugita M; Sagawa M
Surg Today; 2005; 35(10):883-5. PubMed ID: 16175472
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer.
Kataoka Y; Hirano K; Narabayashi T; Hara S; Fujimoto D; Tanaka T; Ebi N; Tomii K; Yoshioka H
Anticancer Res; 2018 Jan; 38(1):559-563. PubMed ID: 29277824
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of baseline carcinoembryonic antigen and cytokeratin 19 fragment levels in advanced non-small cell lung cancer.
Baek AR; Seo HJ; Lee JH; Park SW; Jang AS; Paik SH; Koh ES; Shin HK; Kim DJ
Cancer Biomark; 2018; 22(1):55-62. PubMed ID: 29630519
[TBL] [Abstract][Full Text] [Related]
12. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis value of serum NKX2-1 for primary lung cancer].
Yang L; Ruan WJ; Chen EG; Ying KJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 41(5):535-9. PubMed ID: 23086646
[TBL] [Abstract][Full Text] [Related]
14. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
Liu FY; Chen JS; Changchien CR; Yeh CY; Liu SH; Ho KC; Yen TC
Dis Colon Rectum; 2005 Oct; 48(10):1900-12. PubMed ID: 15991059
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen elevation in agnogenic myeloid metaplasia.
Withofs M; Offner F; de Paepe P; Praet M
Br J Haematol; 2000 Sep; 110(3):743-4. PubMed ID: 11032432
[No Abstract] [Full Text] [Related]
16. Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer.
Wang H; Zhang X; Liu X; Liu K; Li Y; Xu H
J Cancer Res Ther; 2016; 12(1):355-8. PubMed ID: 27072263
[TBL] [Abstract][Full Text] [Related]
17. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
Nutini S; Cappelli G; Benucci A; Catalani C; Nozzoli F
Int J Biol Markers; 1990; 5(4):198-202. PubMed ID: 1965544
[TBL] [Abstract][Full Text] [Related]
18. Primary thymic adenocarcinoma with production of carbohydrate antigen 19-9 and carcinoembryonic antigen.
Misao T; Yamamoto Y; Nakano H; Toyooka S; Yamane M; Satoh K
Jpn J Thorac Cardiovasc Surg; 2004 Jan; 52(1):30-2. PubMed ID: 14760989
[TBL] [Abstract][Full Text] [Related]
19. [Use of determination of the serum carcinoembryonic antigen in oncopulmonology].
Lazarev SM; Reshetov AV; Nikolaev GV; Volgin GN; Nokhrin AV; Kokorin DM
Vestn Khir Im I I Grek; 2009; 168(3):21-5. PubMed ID: 19663274
[TBL] [Abstract][Full Text] [Related]
20. Pathologic stage I non-small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: clinicopathologic characteristics and prognosis.
Matsuguma H; Nakahara R; Igarashi S; Ishikawa Y; Suzuki H; Miyazawa N; Honjo S; Yokoi K
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):44-9. PubMed ID: 18179917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
